Ana B. Enguita

1.2k total citations
39 papers, 679 citations indexed

About

Ana B. Enguita is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, Ana B. Enguita has authored 39 papers receiving a total of 679 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Pulmonary and Respiratory Medicine, 13 papers in Oncology and 11 papers in Cancer Research. Recurrent topics in Ana B. Enguita's work include Lung Cancer Treatments and Mutations (15 papers), Cancer Genomics and Diagnostics (8 papers) and Cancer Immunotherapy and Biomarkers (6 papers). Ana B. Enguita is often cited by papers focused on Lung Cancer Treatments and Mutations (15 papers), Cancer Genomics and Diagnostics (8 papers) and Cancer Immunotherapy and Biomarkers (6 papers). Ana B. Enguita collaborates with scholars based in Spain, United States and United Kingdom. Ana B. Enguita's co-authors include Jon Zugazagoitia, Santiago Ponce-Aix, Enriqueta Felip, Alex Martínez‐Martí, Irene Sansano, S. Cedrés, Alejandro Navarro, Pablo Martínez, José Luis Rodríguez‐Peralto and Luis Paz‐Ares and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Ana B. Enguita

34 papers receiving 663 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ana B. Enguita Spain	14	416	317	152	112	102	39	679
Loralee McMahon United States	13	225 0.5×	280 0.9×	223 1.5×	157 1.4×	74 0.7×	26	608
Yoshika Nagata Japan	18	278 0.7×	356 1.1×	146 1.0×	102 0.9×	58 0.6×	45	706
Hidehiko Shimokawa Japan	17	570 1.4×	435 1.4×	291 1.9×	155 1.4×	103 1.0×	53	971
A. Neuville France	13	166 0.4×	174 0.5×	210 1.4×	108 1.0×	87 0.9×	27	627
Ramona Erber Germany	17	222 0.5×	425 1.3×	183 1.2×	187 1.7×	112 1.1×	83	840
Binglin Yue United States	16	335 0.8×	320 1.0×	194 1.3×	139 1.2×	136 1.3×	41	857
Takeshi Oka Japan	12	252 0.6×	288 0.9×	107 0.7×	118 1.1×	94 0.9×	17	601
Kumaran Mudaliar United States	11	335 0.8×	117 0.4×	168 1.1×	110 1.0×	33 0.3×	37	531
Paweł Teterycz Poland	14	229 0.6×	369 1.2×	147 1.0×	73 0.7×	27 0.3×	62	592
Christiane Rakozy United States	7	154 0.4×	158 0.5×	159 1.0×	181 1.6×	106 1.0×	9	444

Countries citing papers authored by Ana B. Enguita

Since Specialization

Citations

This map shows the geographic impact of Ana B. Enguita's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ana B. Enguita with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ana B. Enguita more than expected).

Fields of papers citing papers by Ana B. Enguita

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ana B. Enguita. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ana B. Enguita. The network helps show where Ana B. Enguita may publish in the future.

Co-authorship network of co-authors of Ana B. Enguita

This figure shows the co-authorship network connecting the top 25 collaborators of Ana B. Enguita. A scholar is included among the top collaborators of Ana B. Enguita based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ana B. Enguita. Ana B. Enguita is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Asín, María Asunción Pérez‐Jacoiste, Javier de la Serna, Ana Pérez‐Ayala, et al.. (2025). Skin and Soft Tissue Mucormycosis in Patients Receiving Bruton Tyrosine Kinase Inhibitors: Case Report and Literature Review. Open Forum Infectious Diseases. 12(12). ofaf691–ofaf691.

Cabo, Horacio, Esther Conde, Susana Hernández, et al.. (2024). Clinical Utility of Combined Tissue and Plasma Next-Generation Sequencing in Patients With Advanced, Treatment-Naïve NSCLC. JTO Clinical and Research Reports. 6(3). 100778–100778.

Lara‐Sáez, Irene, Ángeles Mencía, Yinghao Li, et al.. (2024). Nonviral CRISPR/Cas9 mutagenesis for streamlined generation of mouse lung cancer models. Proceedings of the National Academy of Sciences. 121(28). e2322917121–e2322917121. 2 indexed citations

Arriola, Edurne, Reyes Bernabé, Rosario García Campelo, et al.. (2023). Cost-Effectiveness of Next-Generation Sequencing Versus Single-Gene Testing for the Molecular Diagnosis of Patients With Metastatic Non–Small-Cell Lung Cancer From the Perspective of Spanish Reference Centers. JCO Precision Oncology. 7(7). e2200546–e2200546. 26 indexed citations

Isla, Dolores, María D. Lozano, Luis Paz‐Ares, et al.. (2023). Nueva actualización de las recomendaciones para la determinación de biomarcadores predictivos en el carcinoma de pulmón no célula pequeña: Consenso Nacional de la Sociedad Española de Anatomía Patológica y de la Sociedad Española de Oncología Médica. Revista Española de Patología. 56(2). 97–112. 4 indexed citations

Lorz, Corina, et al.. (2023). Novel Mouse Cell Lines and In Vivo Models for Human High-Grade Neuroendocrine Lung Carcinoma, Small Cell Lung Carcinoma (SCLC), and Large Cell Neuroendocrine Carcinoma (LCNEC). International Journal of Molecular Sciences. 24(20). 15284–15284. 4 indexed citations

Conde, Esther, Susana Hernández, Javier Baena, et al.. (2023). Comparison between liquid biopsy and tissue NGS in two cohorts of advanced NSCLC.. Journal of Clinical Oncology. 41(16_suppl). e21043–e21043.

Isla, Dolores, María D. Lozano, Luis Paz‐Ares, et al.. (2022). New update to the guidelines on testing predictive biomarkers in non-small-cell lung cancer: a National Consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology. Clinical & Translational Oncology. 25(5). 1252–1267. 23 indexed citations

Lorz, Corina, et al.. (2022). Pten and p53 Loss in the Mouse Lung Causes Adenocarcinoma and Sarcomatoid Carcinoma. Cancers. 14(15). 3671–3671. 7 indexed citations

10.

Aix, Santiago Ponce, Enric Carcereny, Joaquim Bosch‐Barrera, et al.. (2021). 160P Pembrolizumab re-challenge in patients with relapsed non-small cell lung cancer (NSCLC): A preliminary report of the REPLAY phase II trial - cohort I. Annals of Oncology. 32. S1450–S1450. 5 indexed citations

11.

Cedrés, S., Santiago Ponce-Aix, Patricia Iranzo, et al.. (2020). Analysis of mismatch repair (MMR) proteins expression in a series of malignant pleural mesothelioma (MPM) patients. Clinical & Translational Oncology. 22(8). 1390–1398. 8 indexed citations

12.

Pérez-Crespo, Míriam, Corina Lorz, Alejandra Bernardini, et al.. (2019). Differential development of large-cell neuroendocrine or small-cell lung carcinoma upon inactivation of 4 tumor suppressor genes. Proceedings of the National Academy of Sciences. 116(44). 22300–22306. 32 indexed citations

13.

Agulló-Ortuño, M. Teresa, Inmaculada García‐Ruiz, C. Vanesa Díaz-García, et al.. (2019). Blood mRNA expression of REV3L and TYMS as potential predictive biomarkers from platinum-based chemotherapy plus pemetrexed in non-small cell lung cancer patients. Cancer Chemotherapy and Pharmacology. 85(3). 525–535. 14 indexed citations

14.

Delgado, Juan F., Manuel Serrano, Ana B. Enguita, et al.. (2017). Early mortality after heart transplantation related to IgA anti–β2-glycoprotein I antibodies. The Journal of Heart and Lung Transplantation. 36(11). 1258–1265. 11 indexed citations

15.

Zugazagoitia, Jon, Daniel Rueda, Ana B. Enguita, et al.. (2017). Prospective Clinical Integration of an Amplicon-Based Next-Generation Sequencing Method to Select Advanced Non–Small-Cell Lung Cancer Patients for Genotype-Tailored Treatments. Clinical Lung Cancer. 19(1). 65–73.e7. 8 indexed citations

16.

Cedrés, S., Santiago Ponce-Aix, Alejandro Navarro, et al.. (2016). Analysis of expression of PTEN/PI3K pathway and programmed cell death ligand 1 (PD-L1) in malignant pleural mesothelioma (MPM). Lung Cancer. 96. 1–6. 31 indexed citations

17.

Zugazagoitia, Jon, Ana B. Enguita, Juan Antonio Vargas, L. Iglesias, & Santiago Ponce. (2014). The new IASLC/ATS/ERS lung adenocarcinoma classification from a clinical perspective: current concepts and future prospects.. PubMed. 6(Suppl 5). S526–36. 46 indexed citations

18.

Carrillo, Rosario, et al.. (2009). Signet-Ring Cell Dermatofibroma. American Journal of Dermatopathology. 31(1). 84–87. 10 indexed citations

19.

Enguita, Ana B., et al.. (2009). Subcutaneous Atypical Fibrous Histiocytoma. American Journal of Dermatopathology. 31(5). 499–501. 11 indexed citations

20.

Enguita, Ana B., et al.. (2008). Eruptive Syringoma Developed Over a Waxing Skin Area. American Journal of Dermatopathology. 30(4). 377–380. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact